Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02458547Completed
Randomised, open-label trial of desflurane in hip fracture (3 arms), sponsored by Yonsei University. Primary endpoints: High Mobility Group Box 1 at 72 hours, Interleukin-6 at 72 hours and 8 more. Started May 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02458547.